<p>Ormeloxifene nanotherapy for cervical cancer treatment</p>
Volume: Volume 14, Pages: 7107 - 7121
Published: Sep 1, 2019
Abstract
Cervical cancer (CxCa) ranks as the fourth most prevalent women-related cancer worldwide. Therefore, there is a crucial need to develop newer treatment modalities. Ormeloxifene (ORM) is a non-steroidal, selective estrogen receptor modulator (SERM) that is used as an oral contraceptive in humans. Recent investigations suggest that ORM exhibits potent anti-cancer activity against various types of cancers. Nanoparticulates offer targeted delivery...
Paper Details
Title
<p>Ormeloxifene nanotherapy for cervical cancer treatment</p>
Published Date
Sep 1, 2019
Volume
Volume 14
Pages
7107 - 7121
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History